Lipid Multiparticulate Technology

Lipid Multiparticulates (LMPs) are round, smooth matrix multiparticulates, typically 50–1,200 μm in diameter depending on the method of manufacture, which consist of one or more GRAS lipid excipients that are solid at room temperature. LMP technology has the capacity to combine a breadth of functionality with a range of finished dosage formats — capsules, sachets, suspensions and tablets. Lonza has developed novel LMP technology based on a proprietary melt-spray-congeal process. This innovative drug delivery approach, which has market precedence, can be used for taste-masking, extended release and bioavailability enhancement for pharmaceutical, health and nutritional products.

Dosage form flexibility for patient-centric drug delivery

Combining the functionality of lipids and flexibility of multiparticulates, LMP technology provides an attractive formulation option for specialized applications, such as pediatrics and geriatric patient groups.